Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zambon is a family-owned global pharmaceutical company founded in 1906 and headquartered in Milan, Italy. The company specializes in the research, development, and commercialization of therapies for respiratory diseases, central nervous system disorders, and rare diseases. Its product portfolio includes well-known brands such as Fluimucil for respiratory health and Monurol for infections, alongside innovative treatments like Xadago for Parkinson's disease. Zambon maintains a strong international presence with operations in over 20 countries and its own manufacturing facilities through Zach System. The company is also committed to innovation through its OpenZone scientific campus, which fosters collaboration within the life sciences community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zambon Italia.